IP Library Granted Patent US 8,552,191
Granted Patent B2
US 8,552,191 · App. 12/531,859 · Granted Oct 8, 2013

Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,552,191
App. No.
12/531,859
Granted
Oct 8, 2013
Kind
B2
Abstract

This application discloses a novel process to synthesize 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds, which may be used, for example, as NK-1 inhibitor compounds in pharmaceutical preparations.

Claims (26)

1. A process for making a lactam compound of Formula I

the process comprising reacting a compound of the Formula 27a-sulfonate

with zinc in the presence of acetic acid, thereby forming the lactam of Formula I, wherein:

R 1 is selected from linear, branched, or cyclic alkyl having up to 6 carbon atoms, phenyl, 2-methoxy-ethyl, 2-(dimethylamino)ethyl, (L)-menthyl, (D)-menthyl, dimethylamide, (R)-benzyl-oxazolidinonamide, (S)-benzyl-oxazolidinonamide, isobornyl, norbornyl, cis-pinan-2-yl, isopinocampheyl, adamantylmethyl, 2-adamantyl, 1-adamantyl, and (−)-8-phenylmenthyl; and

R 5 is selected from methyl, alkyl, benzyl, and p-toluoyl.

2. The process of claim 1 wherein the compound of Formula 27a-sulfonate is prepared by reacting the compound of Formula V,

with an R 1 -acrylate compound of Formula 28a,

in the presence of a base under Michael addition reaction conditions, and selectively precipitating the compound of Formula 27a-sulfonate by reacting the product with a sulfonic acid of the formula R 5 —SO 3 H,

wherein:

R 1 is selected from a linear, branched, or cyclic alkyl having up to 6 carbon atoms, phenyl, 2-methoxy-ethyl, 2-(dimethylamino)ethyl, (L)-menthyl, (D)-Menthyl, Dimethylamide, (R)-Benzyl-oxazolidinonamide, (S)-benzyl-oxazolidinonamide, isobornyl, norbornyl, cis-pinan-2-yl, isopinocampheyl, adamantylmethyl, 2-adamantyl, 1-adamantyl, and (−)-8-phenylmenthyl, and

R 5 is selected from methyl, alkyl, benzyl, and p-toluoyl.

3. The process of claim 2 wherein R 1 is selected from norbornyl and methyl.

4. The process of claim 2 wherein the base is a basic alumina.

5. The process of claim 3 , wherein the base is basic alumina having a Brockman activity of IV.

6. The process of claim 1 wherein the compound of Formula 27a-sulfonate is prepared by:

(a) reacting the compound of Formula IIIB,

with an R 1 -acrylate compound of Formula 28a,

in the presence of a base under Michael addition reaction conditions to form the compound of Formula IIIBa,

wherein R 1 is selected from linear, branched, or cyclic alkyl having up to 6 carbon atoms, phenyl, 2-methoxy-ethyl, 2-(dimethylamino)ethyl, (L)-menthyl, (D)-menthyl, dimethylamide, (R)-benzyl-oxazolidinonamide, (S)-benzyl-oxazolidinonamide, isobornyl, norbornyl, cis-pinan-2-yl, isopinocampheyl, adamantylmethyl, 2-adamantyl, 1-adamantyl, and (−)-8-phenylmenthyl;

(b) deprotecting the compound of Formula IIIBa by reaction with hydrogen in the presence of a palladium catalyst to form the compounds of Formula 27a and 27b

(c) selectively precipitating the compound of Formula 27a-sulfonate by reacting the compounds of Formula 27a and 27b with a sulfonic acid of the formula R 5 —SO 3 H, wherein R 5 is selected from methyl, alkyl, benzyl, and p-toluoyl.

7. The process of claim 1 wherein, R 1 is selected from methyl and isobornyl.

8. The process of claim 7 wherein R 1 methyl.

9. The process of claim 1 wherein R 1 is methyl, (−)-8-phenylmenthyl, isobornyl, 1-adamantanyl, 2-adamantanyl, adamantylmethyl or (+)-isopinocampheyl.

10. The process of claim 3 wherein the base is a basic alumina.

11. The process of claim 2 , wherein the base is basic alumina having a Brockman activity of IV.

Assignments (5)
RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENTS AT R/F 41939/0487, 46591/0544 AND 53940/0001 Recorded Apr 15, 2026
From: MIDCAP FINANCIAL TRUST
To: TERSERA THERAPEUTICS LLC,
Reel/Frame 075420/0453 →
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2023
From: MIDCAP FINANCIAL TRUST, AS AGENT
To: TERSERA THERAPEUTICS LLC
Reel/Frame 063253/0942 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Jul 19, 2018
From: TERSERA THERAPEUTICS LLC
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046591/0544 →
CHANGE OF NAME Recorded Apr 21, 2010
From: SCHERING CORPORATION
To: OPKO HEALTH, INC.
Reel/Frame 024264/0630 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2010
From: MERGELSBERG, INGRID; SCHERER, DOMINIK HERMANN; HUTTENLOCH, MONIKA ERIKA; TSUI, HON-CHUNG; PALIWAL, SUNIL; SHIH, NENG YANG
To: SCHERING CORPORATION
Reel/Frame 024237/0831 →